SEC Form 4 · accession 0001144204-18-059492
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Patience
Director · 10% Owner
Period of report
Nov 8, 2018
Accepted (ET)
Nov 13, 2018 · 9:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 8, 2018 | P | 10,000 | $14.96 | A | 39,411 | I | By John Patience Defined Benefit Pension Plan |
| Common Stock | holding | — | — | — | 4,191,211 | I | By John Patience Trust dated 7/23/1993 | |
| Common StockF2 | holding | — | — | — | 2,110,662 | I | By Patience Enterprises LP | |
| Common Stock | holding | — | — | — | 44,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.96 to $15.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the range.
- F2The reporting person disclaims beneficial ownership of these securities except in the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.